CANNABIS SCIENCE
Law and policy documents, representing cannabis policy research
Oct 18, 2026
What Happens After Cannabis Laws Change? A Review of 176 Policy Studies
Child therapy support session
Oct 17, 2026
Cannabis Science Full Report: What a Phase 2 CBD Autism Trial Found
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protoc
Oct 17, 2026
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protocols
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 17, 2026
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Oct 17, 2026
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,00
Oct 16, 2026
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 16, 2026
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review
Pharmacy research setting representing CBD pharmacology
Oct 16, 2026
Low-Dose CBD and Therapeutic Value: What the New Clinical Pharmacology Review Found
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed C
Oct 16, 2026
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed Cohorts
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Revi
Oct 16, 2026
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Review
Physical therapy session, representing chronic pain research
Oct 16, 2026
Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
Clinical Pharmacology of Cannabinoids and Anticoagulant Interactions - Dr. Benjamin Caplan
Oct 15, 2026
Cannabinoids & Blood Thinners & Anticoagulants: Evidence, Pharmacokinetics & Safety Review
Law and policy documents, representing cannabis policy research
Oct 18, 2026
What Happens After Cannabis Laws Change? A Review of 176 Policy Studies
Child therapy support session
Oct 17, 2026
Cannabis Science Full Report: What a Phase 2 CBD Autism Trial Found
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protoc
Oct 17, 2026
Real-World Evidence: Cannabinoid Therapy in Patients on Incretin (GLP-1 RA) Weight Management Protocols
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 17, 2026
Cannabinoids & Statins & Lipid-Lowering Agents: Evidence, Pharmacokinetics & Safety Review
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Oct 17, 2026
Cannabinoid Hyperemesis Syndrome (CHS): Concentrates, Hot Water Relief & Absolute Cessation Criteria
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,00
Oct 16, 2026
Real-World Evidence: Sleep Latency, Nocturnal Awakenings & Minor Cannabinoids (CBN/CBG) across 24,000+ Visits
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review - Dr. Ben
Oct 16, 2026
Cannabinoids & Antidepressants & SSRIs / SNRIs: Evidence, Pharmacokinetics & Safety Review
Pharmacy research setting representing CBD pharmacology
Oct 16, 2026
Low-Dose CBD and Therapeutic Value: What the New Clinical Pharmacology Review Found
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed C
Oct 16, 2026
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed Cohorts
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Revi
Oct 16, 2026
Cannabinoids & Incretin Mimetics & GLP-1 Receptor Agonists: Evidence, Pharmacokinetics & Safety Review
Physical therapy session, representing chronic pain research
Oct 16, 2026
Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
Clinical Pharmacology of Cannabinoids and Anticoagulant Interactions - Dr. Benjamin Caplan
Oct 15, 2026
Cannabinoids & Blood Thinners & Anticoagulants: Evidence, Pharmacokinetics & Safety Review
CANNABIS NEWS
cbd gummies and fatty liver what the evidence sho
Oct 18, 2026
CBD Gummies and Fatty Liver: What the Evidence Shows and Practical Considerations
Editorial image for CBD Gummies for Men: A Practical Look at Daily Use, Evidence, and Real-World Fit
Oct 18, 2026
CBD Gummies for Men: A Practical Look at Daily Use, Evidence, and Real-World Fit
cbd gummies and heart health what the evidence re
Oct 18, 2026
CBD Gummies and Heart Health: What the Evidence Really Shows for Everyday Use
cbd gummies for sex what real experience and avai
Oct 18, 2026
CBD Gummies for Sex: What Real Experience and Available Evidence Actually Show
green otter cbd gummies for copd what users and e
Oct 18, 2026
Green Otter CBD Gummies for COPD: What Users and Evidence Actually Show
boost cbd gummies hair growth what the evidence s
Oct 17, 2026
Boost CBD Gummies Hair Growth: Evidence and Wellness Insights
ced pexels 7468580
Oct 17, 2026
CBD Gummies for Social Anxiety: What the Evidence Shows and How They Fit into Daily Routines
Editorial image for CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
Oct 17, 2026
CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
ced pexels 6942071
Oct 17, 2026
CBD Gummies for Autism Symptoms – Clinical Insights
cbd gummies for lung issues what the evidence sho 1
Oct 17, 2026
CBD Gummies for Lung Issues: What the Evidence Shows and How They Fit Into Daily Wellness
cbd gummies and psychosis what the evidence shows
Oct 16, 2026
CBD Gummies and Psychosis: What the Evidence Shows for Everyday Use
does cbd gummies make you sleepy what the evidenc 1
Oct 16, 2026
Does CBD Gummies Make You Sleepy? What the Evidence and Experience Actually Show
cbd gummies and fatty liver what the evidence sho
Oct 18, 2026
CBD Gummies and Fatty Liver: What the Evidence Shows and Practical Considerations
Editorial image for CBD Gummies for Men: A Practical Look at Daily Use, Evidence, and Real-World Fit
Oct 18, 2026
CBD Gummies for Men: A Practical Look at Daily Use, Evidence, and Real-World Fit
cbd gummies and heart health what the evidence re
Oct 18, 2026
CBD Gummies and Heart Health: What the Evidence Really Shows for Everyday Use
cbd gummies for sex what real experience and avai
Oct 18, 2026
CBD Gummies for Sex: What Real Experience and Available Evidence Actually Show
green otter cbd gummies for copd what users and e
Oct 18, 2026
Green Otter CBD Gummies for COPD: What Users and Evidence Actually Show
boost cbd gummies hair growth what the evidence s
Oct 17, 2026
Boost CBD Gummies Hair Growth: Evidence and Wellness Insights
ced pexels 7468580
Oct 17, 2026
CBD Gummies for Social Anxiety: What the Evidence Shows and How They Fit into Daily Routines
Editorial image for CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
Oct 17, 2026
CBD Gummies to Lower Blood Sugar: What the Evidence Actually Shows
ced pexels 6942071
Oct 17, 2026
CBD Gummies for Autism Symptoms – Clinical Insights
cbd gummies for lung issues what the evidence sho 1
Oct 17, 2026
CBD Gummies for Lung Issues: What the Evidence Shows and How They Fit Into Daily Wellness
cbd gummies and psychosis what the evidence shows
Oct 16, 2026
CBD Gummies and Psychosis: What the Evidence Shows for Everyday Use
does cbd gummies make you sleepy what the evidenc 1
Oct 16, 2026
Does CBD Gummies Make You Sleepy? What the Evidence and Experience Actually Show
Browse Tag

Trump Administration Medical Marijuana Reclassification, Federal Cannabis Policy Change, Medical Marijuana Research Barriers, Cannabis Rescheduling Impact, Clinical Cannabis Dosing Evidence

1 Article
trump administration reclassifies medical marijuan
Cannabis News

Trump Administration Reclassifies Medical Marijuana, Marking Significant Policy Change

Dr. Benjamin Caplan, MD By Benjamin Caplan, MD
Comments Off on Trump Administration Reclassifies Medical Marijuana, Marking Significant Policy Change
April 23, 2026
4 Min Read

The trump administration medical marijuana reclassification marks a pivotal federal cannabis policy change. This shift removes research barriers, enabling better clinical dosing evidence. It opens new opportunities for rigorous medical marijuana research.

Copyright 2026 CED Clinic. All rights reserved.
Research Assistant
CED Clinic Research Assistant (beta)
Answers are generated by software, not written by Dr. Caplan
CED Clinic Research Assistant (beta) Answers are generated by software from published research. They are not written or reviewed by Dr. Caplan.
This is a beta system and its answers may contain errors. For any medical question, please consult a licensed clinician who knows you and your personal medical history.
This assistant explains what published studies say in general terms. It cannot advise on your dose, your medications or your treatment plan, and it will not use your name. Please do not include personal details.
Example questions:
CED Clinic Research Assistant (beta). Educational only. Not medical advice.
CED Clinic
CED Clinic Home
Explore
Cannabis Science
Research & Clinical
Cannabis News
Policy, Humor & News
Metabolic Health
GLP-1 Care & Science
Cannabis Recipes
Infused Foods & Drinks
Book an Appointment Contact CED Clinic
Recent Posts
Loading…
MENU